Masashi Mizokami

发表

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure

S. Suzuki, K. Tokunaga, M. Sugiyama, 2021, Frontiers in Immunology.

New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease.

M. Kurosaki, K. Matsuura, M. Sugiyama, 2023, Journal of gastroenterology.

Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan

M. Sugiyama, M. Mizokami, T. Kanto, 2018, Journal of viral hepatitis.

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

Alexander E. Lopez, Aaron M. King, Andrew L Blumenfeld, 2021, Journal of hepatology.

Potential of Mac‐2‐binding protein glycan isomer as a new therapeutic target in pancreatic cancer

T. Yokobori, N. Harimoto, K. Araki, 2024, Cancer science.

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy

M. Sugiyama, Tadaki Suzuki, M. Ishikane, 2022 .

Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication

Y. Matsuura, Tetsuro Suzuki, I. Shoji, 2023, Journal of virology.

Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals.

M. Honda, S. Kaneko, M. Kurosaki, 2015, Tissue antigens.

Resistance Analyses of Japanese Hepatitis C‐Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies

N. Izumi, H. Mo, M. Mizokami, 2016, Journal of Viral Hepatitis.

Complete Match of Streptococcus salivarius from Oral Saliva and Stool in a Patient with Hepatic Encephalopathy.

H. Hidaka, H. Uojima, K. Horio, 2024, Internal medicine.